Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran
Bibliographic Data
Schizophrenia Spectrum Disorder (SSD) is a chronic psychiatric disorder with a modest treatment outcome. In addition, relapses are commonplace. Here, we sought to identify factors that predict relapse latency and frequency. To this end, we retrospectively analyzed data for individuals with SSD. Medical records of 401 individuals with SSD were analyzed (mean age: 25.51 years; 63.6% males) covering a five-year period. Univariate and multivariate Penalized Likelihood Models with Shared Log-Normal Frailty were used to determine the correlation between discharge time and relapse and to identify risk factors. A total of 683 relapses were observed in males, and 422 relapses in females. The Relapse Hazard Ratio (RHR) decreased with age (RHR = 0.99, CI: (0.98-0.998)) and with participants' adherence to pharmacological treatment (HR = 0.71, CI: 0.58-0.86). In contrast, RHR increased with a history of suicide attempts (HR = 1.32, CI: 1.09-1.60), and a gradual compared to a sudden onset of disease (HR = 1.45, CI: 1.02-2.05). Gender was not predictive. Data indicate that preventive and therapeutic interventions may be particularly important for individuals who are younger at disease onset, have a history of suicide attempts, have experienced a gradual onset of disease, and have difficulties adhering to medication
Age of onset · Confidence interval · Disease · Hazard ratio · Medical record · Multivariate analysis · Proportional hazards model · Psychiatry · Psychological intervention · Psychosis · Schizophrenia (object-oriented programming · Schizophrenia Spectrum · Bipolar Disorder and Treatment · Medicine · Schizophrenia research and treatment · Treatment of Major Depression · Internal Medicine
Caregivers’ experiences and perspectives of factors associated with relapse in Iranian people living with schizophrenia
Sex-dependent association of DNA methylation in the coding region of the corticotropin-releasing hormone gene and schizophrenia spectrum disorder
Assessment of Antipsychotic Medications on Social Media
Diagnostic and Statistical Manual of Mental Disorders
The psychology of suicidal behaviour
Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder
Retracted
EPA guidance on physical activity as a treatment for severe mental illness
A Neural Basis for the Acquired Capability for Suicide
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Barriers to Family Caregivers' Coping With Patients With Severe Mental Illness in Iran
| Citations per year | 0.6 |
|---|---|
| Citation span | 2021 - 2023 (3) |
| Highly cited | No |